Home > Balance Sheet > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Deferred Tax Assets / Liabilities ₹-3,133 Cr₹-2,818 Cr₹-3,512 Cr₹-3,117 Cr₹-2,451 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?

The latest Deferred Tax Assets / Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES is ₹-3,133 Cr based on Mar2023 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2023₹-3,133 Cr
Mar2022₹-2,818 Cr
Mar2021₹-3,512 Cr
Mar2020₹-3,117 Cr
Mar2019₹-2,451 Cr

How is Deferred Tax Assets / Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2023 ₹-3,133 Cr
Negative
Mar2022 ₹-2,818 Cr
Negative
Mar2021 ₹-3,512 Cr
Negative
Mar2020 ₹-3,117 Cr
Negative
Mar2019 ₹-2,451 Cr -

Compare Deferred Tax Assets / Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹367,020.9 Cr 0.5% -5.7% 55.1% Stock Analytics
CIPLA ₹114,925.0 Cr 1.1% -4.4% 55.5% Stock Analytics
DIVIS LABORATORIES ₹105,128.0 Cr -0.7% 9.4% 21.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,109.0 Cr 0.1% 1.1% 28.1% Stock Analytics
ZYDUS LIFESCIENCES ₹102,736.0 Cr 6% 2.8% 93.1% Stock Analytics
MANKIND PHARMA ₹91,490.4 Cr -4.2% -4.7% NA Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

0.5%

-5.7%

55.1%

SENSEX

0.2%

-0.2%

20.9%


You may also like the below Video Courses